Amundi Has $506.57 Million Position in Synopsys, Inc. $SNPS

Amundi grew its position in shares of Synopsys, Inc. (NASDAQ:SNPS) by 16.8% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 968,384 shares of the semiconductor company’s stock after purchasing an additional 139,311 shares during the quarter. Amundi’s holdings in Synopsys were worth $506,571,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in SNPS. Brighton Jones LLC boosted its position in Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company’s stock worth $447,000 after buying an additional 50 shares during the period. Harbour Investments Inc. raised its stake in shares of Synopsys by 10.8% during the first quarter. Harbour Investments Inc. now owns 235 shares of the semiconductor company’s stock valued at $101,000 after acquiring an additional 23 shares during the last quarter. Atria Wealth Solutions Inc. lifted its holdings in shares of Synopsys by 28.9% during the first quarter. Atria Wealth Solutions Inc. now owns 5,679 shares of the semiconductor company’s stock worth $2,435,000 after purchasing an additional 1,272 shares during the period. Vanguard Group Inc. grew its stake in shares of Synopsys by 2.4% in the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after purchasing an additional 346,994 shares during the last quarter. Finally, Primecap Management Co. CA acquired a new stake in Synopsys in the first quarter valued at $17,754,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Synopsys Stock Down 0.6%

Synopsys stock opened at $463.74 on Friday. The company has a market capitalization of $86.14 billion, a PE ratio of 36.40, a PEG ratio of 5.35 and a beta of 1.16. Synopsys, Inc. has a 12-month low of $365.74 and a 12-month high of $651.73. The firm’s fifty day moving average is $437.46 and its 200 day moving average is $505.76. The company has a quick ratio of 1.51, a current ratio of 1.62 and a debt-to-equity ratio of 0.52.

Synopsys (NASDAQ:SNPS) last posted its quarterly earnings results on Tuesday, September 9th. The semiconductor company reported $2.30 earnings per share for the quarter, missing the consensus estimate of $3.75 by ($1.45). Synopsys had a net margin of 31.04% and a return on equity of 10.82%. The company had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.77 billion. During the same period last year, the firm posted $3.43 earnings per share. The company’s revenue for the quarter was up 14.0% on a year-over-year basis. Synopsys has set its FY 2025 guidance at 12.760-12.800 EPS and its Q4 2025 guidance at 2.760-2.80 EPS. As a group, sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current fiscal year.

Insider Transactions at Synopsys

In other news, Director Robert G. Painter acquired 350 shares of the firm’s stock in a transaction dated Thursday, September 11th. The stock was purchased at an average price of $425.44 per share, for a total transaction of $148,904.00. Following the completion of the acquisition, the director directly owned 2,291 shares in the company, valued at $974,683.04. The trade was a 18.03% increase in their position. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CAO Sudhindra Kankanwadi sold 9,873 shares of the stock in a transaction on Monday, September 22nd. The stock was sold at an average price of $500.90, for a total value of $4,945,385.70. Following the completion of the transaction, the chief accounting officer owned 20,520 shares in the company, valued at approximately $10,278,468. This represents a 32.48% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders own 0.62% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on SNPS shares. Wells Fargo & Company cut their target price on Synopsys from $550.00 to $445.00 and set an “equal weight” rating on the stock in a report on Tuesday, November 25th. Rosenblatt Securities restated a “neutral” rating and set a $605.00 price objective (down from $650.00) on shares of Synopsys in a research report on Wednesday, September 10th. Piper Sandler reduced their target price on Synopsys from $660.00 to $630.00 and set an “overweight” rating on the stock in a report on Wednesday, September 10th. Citigroup assumed coverage on shares of Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 target price for the company. Finally, Bank of America restated an “underperform” rating and issued a $525.00 price target (down previously from $625.00) on shares of Synopsys in a research report on Wednesday, September 10th. Ten equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Hold” and an average target price of $555.33.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.